Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study

Steuwe C, Rullkötter N, Ertl V, Berg M, Neuner F, Beblo T, Driessen M (2016)
BMC Psychiatry 16(1).

Download
OA 709.45 KB
Journal Article | Published | English
Author
; ; ; ; ; ;
Abstract
Background This pilot study focused on the feasibility and potential effectiveness of a protocol based on Narrative Exposure Therapy (NET) that was integrated into a standard inpatient program to treat patients with comorbid Borderline Personality Disorder (BPD) and Posttraumatic Stress Disorder (PTSD). Methods Eleven patients (1 male, 10 female) without previous stabilization periods or the absence of intentional self-injury received NET during a ten-week inpatient program. Patients were assessed again at post-treatment and a 12-month follow-up. Results Drop-out rates during treatment were low, with 90.9 % completing NET. Furthermore, acceptance of NET was high, with only one patient rejecting treatment. The program was safe because it did not lead to aggravations in symptom severity at either the post-treatment or 12-month follow-up. Additionally, the rate of self-harming behaviors throughout the treatment phase was low (18.2 %). In fact, treatment was associated with positive effects on PTSD and BPD symptom severity as well as secondary outcome measures, including depression, dissociation and quality of life. Conclusions The present study found that NET is feasible and safe in an inpatient setting for treating highly burdened patients with BPD and PTSD. There is also evidence for the potential effectiveness of NET in this highly burdened population.
Publishing Year
ISSN
Financial disclosure
Article Processing Charge funded by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.
PUB-ID

Cite this

Steuwe C, Rullkötter N, Ertl V, et al. Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study. BMC Psychiatry. 2016;16(1).
Steuwe, C., Rullkötter, N., Ertl, V., Berg, M., Neuner, F., Beblo, T., & Driessen, M. (2016). Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study. BMC Psychiatry, 16(1), 254. doi:10.1186/s12888-016-0969-4
Steuwe, C., Rullkötter, N., Ertl, V., Berg, M., Neuner, F., Beblo, T., and Driessen, M. (2016). Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study. BMC Psychiatry 16.
Steuwe, C., et al., 2016. Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study. BMC Psychiatry, 16(1).
C. Steuwe, et al., “Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study”, BMC Psychiatry, vol. 16, 2016.
Steuwe, C., Rullkötter, N., Ertl, V., Berg, M., Neuner, F., Beblo, T., Driessen, M.: Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study. BMC Psychiatry. 16, (2016).
Steuwe, Carolin, Rullkötter, Nina, Ertl, Verena, Berg, Michaela, Neuner, Frank, Beblo, Thomas, and Driessen, Martin. “Effectiveness and feasibility of Narrative Exposure Therapy (NET) in patients with borderline personality disorder and posttraumatic stress disorder – a pilot study”. BMC Psychiatry 16.1 (2016).
Main File(s)
File Name
Access Level
OA Open Access
Last Uploaded
2016-08-08T12:07:32Z

This data publication is cited in the following publications:
This publication cites the following data publications:

47 References

Data provided by Europe PubMed Central.


AUTHOR UNKNOWN, 2000

Schauer M, Neuner F, Elbert T., 2011
Narrative Exposition
Neuner F, Schauer M, Elbert T., 2013

First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS., 1997

First MB, Spitzer RL, Gibbon M, Williams JBW., 2002

Bernstein D, Fink L., 1998

Ehlers A, Steil R, Winter H, Foa EB., 1996
The validation of a self-report measure of posttraumatic stress disorder: the posttraumatic diagnostic scale
Foa EB, Cashman L, Jaycox L, Perry K., 1997
[Development of the Borderline Symptom List]
Bohus M, Limberger MF, Frank U, Sender I, Gratwohl T, Stieglitz RD., Psychother Psychosom Med Psychol 51(5), 2001
PMID: 11417358

Spitzer C, Stieglitz RD, Freyberger H-J., 2005
Development, reliability, and validity of a dissociation scale.
Bernstein EM, Putnam FW., J. Nerv. Ment. Dis. 174(12), 1986
PMID: 3783140

Hautzinger M, Keller F, Kühner C., 2006

Angermeyer MC, Kilian R, Matschinger H., 2000

Cohen J., 1988
[The treatment history of patients with borderline personality disorder in the Republic of Germany]
Jerschke S, Meixner K, Richter H, Bohus M., Fortschr Neurol Psychiatr 66(12), 1998
PMID: 9922927
Evaluation of narrative exposure therapy (NET) for borderline personality disorder with comorbid posttraumatic stress disorder
Pabst A, Schauer M, Bernhardt K, Ruf-Leuschner M, Goder R, Elbert T, Rosentraeger R, Robjant K, Aldenhoff J, Seeck-Hirschner M., 2014
[Psychotherapists' attitudes towards the treatment of patients with borderline personality disorder].
Jobst A, Horz S, Birkhofer A, Martius P, Rentrop M., Psychother Psychosom Med Psychol 60(3-4), 2010
PMID: 19452423
A survey of psychologists' attitudes towards and utilization of exposure therapy for PTSD.
Becker CB, Zayfert C, Anderson E., Behav Res Ther 42(3), 2004
PMID: 14975770
Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial.
Bohus M, Haaf B, Simms T, Limberger MF, Schmahl C, Unckel C, Lieb K, Linehan MM., Behav Res Ther 42(5), 2004
PMID: 15033496

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 27439618
PubMed | Europe PMC

Search this title in

Google Scholar